We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Bone marrow- and adipose-derived stem cells show expression of myelin mRNAs and proteins

    Cristina Mantovani

    Blond McIndoe Laboratories, Tissue Injury & Repair Group, The University of Manchester, Manchester, UK

    Departments of Anatomy & Surgical & Perioperative Science, University Hospital, Umeå, Sweden

    ,
    Daljeet Mahay

    Blond McIndoe Laboratories, Tissue Injury & Repair Group, The University of Manchester, Manchester, UK

    ,
    Paul J Kingham

    Blond McIndoe Laboratories, Tissue Injury & Repair Group, The University of Manchester, Manchester, UK

    ,
    Giorgio Terenghi

    Blond McIndoe Laboratories, Tissue Injury & Repair Group, The University of Manchester, Manchester, UK

    , &
    Mikael Wiberg

    Departments of Anatomy & Surgical & Perioperative Science, University Hospital, Umeå, Sweden

    Published Online:https://doi.org/10.2217/rme.10.15

    Aims: PNS myelin is formed by Schwann cells (SCs). In this study, we applied an in vitro model to study myelin formation, using bone marrow mesenchymal stem cells and adipose-derived stem cells differentiated into SC-like cells and co-cultured with dissociated adult dorsal root ganglia neurons. Methods: Immunocytochemistry, reverse transcription-PCR and western blotting techniques were used to investigate the expression of myelin proteins at both the transcriptional and translational level. Results: Transcripts for protein zero, peripheral myelin protein 22 and myelin basic protein were detected in differentiated stem cells following co-culture with neuronal cells. Furthermore, protein zero, peripheral myelin protein 22 and myelin basic proteins were recognized in the co-cultures. These results were consistent with immunostaining of myelin proteins and with observation by electron microscopy. Conclusion: Both types of adult stems cells differentiated into SC-like cells have potential to myelinate neuronal cells during regeneration, being functionally identical to SCs of the PNS.

    Bibliography

    • Snipes GJ, Suter U, Welcher AA, Shooter EM: Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). J. Cell Biol.117,225–238 (1992).
    • Schachner M, Bartsch U: Multiple functions of the myelin-associated glycoprotein MAG (siglec-4a) in formation and maintenance of myelin. Glia29,154–165 (2000).
    • Quarles RH: Glycoproteins of myelin sheaths. J. Mol. Neurosci.8,1–12 (1997).
    • Pareek S, Suter U, Snipes GJ et al.: Detection and processing of peripheral myelin protein PMP-22 in cultured Schwann cells. J. Biol. Chem.268,10372–10379 (1993).
    • Greenfield S, Weise MJ, Gantt G et al.: Basic proteins of rodent peripheral nerve myelin: immunochemical identification of the 21.5K, 18.5K, 17K, 14K, and P2 proteins. J. Neurochem.39,1278–1282 (1982).
    • Snipes GJ, Suter U: Molecular anatomy and genetics of myelin proteins in the peripheral nervous system. J. Anat.186(3),483–494 (1995).
    • Yin Q, Kemp GJ, Yu LG et al.: Expression of Schwann cell-specific proteins and low-molecular-weight neurofilament protein during regeneration of sciatic nerve treated with neurotrophin-4. Neuroscience105,779–783 (2001).
    • Yin X, Crawford TO, Griffin JW et al.: Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J. Neurosci.18,1953–1962 (1998).
    • Caddick J, Kingham PJ, Gardiner NJ et al.: Phenotypic and functional characteristics of mesenchymal stem cells differentiated along a Schwann cell lineage. Glia54,840–849 (2006).
    • 10  Tohill M, Terenghi G: Stem-cell plasticity and therapy for injuries of the peripheral nervous system. Biotechnol. Appl. Biochem.40,17–24 (2004).
    • 11  Kingham PJ, Kalbermatten DF, Mahay D et al.: Adipose-derived stem cells differentiate into a Schwann cell phenotype and promote neurite outgrowth in vitro. Exp. Neurol.207,267–274 (2007).
    • 12  Mahay D, Terenghi G, Shawcross SG: Growth factors in mesenchymal stem cells following glial cell differentiation. Biotechnol. Appl. Biochem.51,167–176 (2008).
    • 13  Martini R: Introduction to myelin formation and maintenance. Microsc. Res. Tech.41,341–343 (1998).
    • 14  Yang J, Lou Q, Huang R et al.: Dorsal root ganglion neurons induce transdifferentiation of mesenchymal stem cells along a Schwann cell lineage. Neurosci. Lett.445,246–251 (2008).
    • 15  Brockes JP, Fields KL, Raff MC: Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res.165,105–118 (1979).
    • 16  Mosahebi A, Simon M, Wiberg M, Terenghi G: A novel use of alginate hydrogel as Schwann cell matrix. Tissue Eng.7,525–534 (2001).
    • 17  Mahay D, Terenghi D, Shawcross SG: Schwann cell mediated trophic effects by differentiated mesenchymal stem cells. Exp. Cell Res.314,2692–2701 (2008).
    • 18  Keilhoff G, Stang F, Goihl A et al.: Transdifferentiated mesenchymal stem cells as alternative therapy in supporting nerve regeneration and myelination. Cell. Mol. Neurobiol.26,1235–1252 (2006).
    • 19  Obremski VJ, Bunge MB: Addition of purified basal lamina molecules enables Schwann cell ensheathment of sympathetic neurites in culture. Dev. Biol.168,124–137 (1995).
    • 20  Choi KC, Yoo DS, Cho KS et al.: Effect of single growth factor and growth factor combinations on differentiation of neural stem cells. J. Korean Neurosurg. Soc.44,375–381 (2008).
    • 21  Jessen KR, Mirsky R: Schwann cells and their precursors emerge as major regulators of nerve development. Trends Neurosci.22,402–410 (1999).
    • 22  Fernandez R, Pena E, Navascues J et al.: cAMP-dependent reorganization of the Cajal bodies and splicing machinery in cultured Schwann cells. Glia40,378–388 (2002).
    • 23  D’Urso D, Ehrhardt P, Muller HW: Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin. J. Neurosci.19,3396–3403 (1999).
    • 24  Shine HD, Readhead C, Popko B et al.: Morphometric analysis of normal, mutant, and transgenic CNS: correlation of myelin basic protein expression to myelinogenesis. J. Neurochem.58,342–349 (1992).
    • 25  Martini R, Schachner M: Molecular bases of myelin formation as revealed by investigations on mice deficient in glial cell surface molecules. Glia19,298–310 (1997).
    • 26  Niemann S, Sereda MW, Suter U et al.: Uncoupling of myelin assembly and schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22. J. Neurosci.20,4120–4128 (2000).
    • 27  Segovia J, Lawless GM, Tillakaratne NJK et al.: Cyclic AMP decreases the expression of a neuronal marker (GAD67) and increases the expression of an astroglial marker (GFAP) in C6 cells. J. Neurochem.63,1218–1225 (1994).